Dolutegravir Sodium Salt

Product Specifications

CAS Number

1051375-19-9

Synonyms

2H-Pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide, N-[(2,4-difluorophenyl)methyl]-3,4,6,8,12,12a-hexahydro-7-hydroxy-4-methyl-6,8-dioxo-, sodium salt (1:1), (4R,12aS)-; Dolutegravir sodium; Dolutegravir sodium salt; GSK 1349572A; GSK 1349572A

Hazard Statement

May cause an allergic skin reaction; UN number: UN3077; Packing Group: III

Purity

>95% (HPLC)

Smiles

[Na+].C[C@@H]1CCO[C@H]2CN3C=C(C(=O)NCc4ccc(F)cc4F)C(=O)C(=C3C(=O)N12)[O-]

Molecular Formula

C20 H18 F2 N3 O5 . Na

Molecular Weight

441.36

InChI

InChI=1S/C20H19F2N3O5.Na/c1-10-4-5-30-15-9-24-8-13(17(26)18(27)16(24)20(29)25(10)15)19(28)23-7-11-2-3-12(21)6-14(11)22;/h2-3,6,8,10,15,27H,4-5,7,9H2,1H3,(H,23,28);/q;+1/p-1/t10-,15+;/m1./s1

Additionnal Information

IUPAC name: sodium;(4R,12aS)-9-[(2,4-difluorophenyl)methylcarbamoyl]-4-methyl-6,8-dioxo-3,4,12,12a-tetrahydro-2H-pyrido[5,6]pyrazino[2,6-b][1,3]oxazin-7-olate

Shipping Conditions

Room Temperature

Storage Conditions

-20°C